PLYMOUTH, Minn., Aug. 6, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the 29th Annual Canaccord Adams Global Growth Conference at 1:00 p.m. Eastern Time on Thursday, August 13, 2009 at the Intercontinental Hotel located at 510 Atlantic Ave, Boston, MA.
To access the webcast, go to the investor relations section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils and flow diversion devices, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
CONTACT: ev3 Inc.
Investors and Media
Julie Tracy, Sr. Vice President, Chief Communications Officer
(949) 680-1375
jtracy@ev3.net
